GEVO Stock Cash Flow Statements

Gevo Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Gevo Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30

operating activities
net income	-21,156,000	-21,002,000	-18,875,000	-18,477,000	-15,700,000	-14,420,000	-17,618,000	-25,387,000	-43,786,000	-13,161,000	-15,673,000	-16,513,000	-14,380,000	-18,253,000	-10,057,000	-18,054,000	-6,836,000	-6,043,000	-9,253,000	-6,815,000	-8,619,000
adjustments to reconcile net income to net cash from operating activities:
stock-based compensation	3,786,000	4,466,000	4,233,000	4,335,000	4,132,000	3,943,000	4,677,000	4,795,000	4,679,000	3,687,000	4,258,000	4,051,000	4,206,000	692,000	925,000	778,000	674,000	501,000	172,000	411,000	568,000
depreciation and amortization	3,494,000	4,277,000	4,451,000	4,684,000	4,994,000	4,754,000	4,575,000	3,435,000	1,536,000	1,474,000	1,442,000	1,556,000	1,200,000	1,223,000	1,149,000	1,151,000	1,476,000	1,629,000	1,649,000	1,807,000	1,628,000
amortization of marketable securities discount
other noncash expense	571,000	620,000	656,000	253,000	304,000	117,000	234,000
changes in operating assets and liabilities, net of effects of acquisition:
accounts receivable	1,076,000	206,000	135,000	-381,000	-1,231,000	-156,000	-379,000	-124,000	-164,000	-20,000	810,000	-271,000	334,000	-755,000	435,000	-157,000	376,000	-594,000	983,000	-757,000	-212,000
inventories	-1,785,000	298,000	-55,000	-467,000	1,000	-514,000	1,650,000	-1,666,000	-440,000	86,000	16,000	-409,000	-125,000	236,000	39,000	295,000	-71,000	201,000	520,000	-239,000	367,000
prepaid expenses and other current assets, deposits and other assets	-4,809,000	-2,644,000	-3,297,000	-24,804,000	12,219,000	-183,000	-12,852,000	-2,448,000	-6,617,000	489,000	-2,317,000	1,330,000	-1,321,000	1,131,000	-4,273,000	1,395,000	-777,000	331,000	-167,000	-1,801,000	590,000
accounts payable, accrued expenses and non-current liabilities	7,803,000	2,337,000	-3,326,000	2,266,000	3,532,000	-3,486,000	381,000
net cash from operating activities	-11,020,000	-11,442,000	-16,078,000	-32,591,000	8,251,000	-9,933,000	-19,446,000	-15,843,000	-19,656,000	-4,654,000	-12,460,000	-14,843,000	-9,225,000	-12,303,000	-7,165,000	-4,757,000	-3,776,000	-3,817,000	-6,988,000	-6,041,000	-5,145,000
investing activities
acquisitions of property, plant and equipment	-9,751,000	-9,196,000	-17,512,000	6,958,000	-32,275,000	-17,704,000	-11,434,000	-7,240,000	-22,370,000	-14,947,000	-31,218,000	-28,707,000	-16,788,000	-9,537,000	-4,630,000	-4,149,000	-136,000	-843,000	-777,000	-210,000	-1,223,000
proceeds from sale of investment tax credit
payment of earnest money deposit
acquisition of cultivateai
proceeds from maturity of marketable securities				0	0
proceeds from sale of property, plant and equipment							67,000													13,000
net cash from investing activities	-10,485,000	-9,196,000	-17,512,000	6,958,000	-32,353,000	15,341,000	124,183,000	48,524,000	53,220,000	-16,211,000	7,861,000	16,365,000	8,544,000	-431,899,000	-4,630,000	-4,149,000	-136,000	-843,000	-777,000	-197,000	-2,704,000
financing activities
proceeds from issuance of remarketed bonds	0
extinguishment of 2021 bonds	0
payment of debt offering costs	0
proceeds from the exercise of warrants
payment of loans payable	-24,000	-33,000	-32,000	-39,000	-48,000
payment of finance lease liabilities	-323,000	-232,000	-23,000	0	0	1,000	-23,000	4,304,000	-4,229,000	-53,000	-34,000	-1,492,000
repurchases of common stock
net cash from financing activities	-944,000			-39,000	-48,000	-40,000	-62,000	4,265,000	-4,268,000	138,919,000	-354,000	-1,662,000	-8,340,000	64,073,000	458,780,000	6,623,000	78,196,000	1,708,000	752,000	1,596,000	-362,000
net increase in cash and cash equivalents	-22,449,000	-25,235,000	-35,042,000	-25,672,000	-24,150,000	5,368,000	104,675,000	36,946,000	29,296,000	118,054,000	-4,953,000				446,985,000	-2,283,000	74,284,000	-2,952,000	-7,013,000	-4,642,000	-8,211,000
cash, cash equivalents and restricted cash at beginning of period	0	0	375,597,000	0	0	0	315,376,000	0	0	0	136,033,000
cash, cash equivalents and restricted cash at end of period	-22,449,000	-25,235,000	340,555,000	-25,672,000	-24,150,000	5,368,000	420,051,000	36,946,000	29,296,000	118,054,000	131,080,000
changes in operating assets and liabilities:
net cash from by financing activities			-1,452,000
impairment loss								0
loss on disposal of assets												0	183,000
amortization of marketable securities (discount) premium				0	0	12,000	-114,000
acquisition of patent portfolio								0	0	0	-10,000
purchase of marketable securities								0	855,000	-99,264,000	-31,993,000	0	0
debt and equity offering costs								0	0			-36,000	-162,000	-3,074,000	-31,683,000	-200,000	-6,055,000	-63,000	-52,000	-54,000	-161,000
proceeds from issuance of common stock and common stock warrants								0	0			1,824,000	0	-1,824,000	489,373,000	6,429,000
proceeds from exercise of warrants								0	0	0	3,000		0	2,000	1,117,000
net settlement of common stock under stock plans								-1,000	1,000	-66,000	-220,000	-1,904,000				-19,000	-21,000			0
proceeds from property, plant and equipment
proceeds from sale and maturity of marketable securities							135,550,000	55,764,000	74,735,000	98,000,000	71,082,000
payment of debt							-39,000
(gain) on forgiveness of sba loans												0
amortization of marketable securities premium								-32,000
other noncash income								1,030,000	-505,000
accounts payable, accrued expenses and long-term liabilities								4,055,000	774,000	1,091,000	-2,285,000				4,545,000	-906,000	857,000			1,039,000	293,000
purchase of patents and license
proceeds from issuance of 2021 bonds												0	0
payment of loans payable - other								-38,000	-40,000	31,000	-103,000		-45,000	-26,000	-27,000		-89,000	-238,000	-154,000
noncash interest expense
non-cash lease expense											139,000	45,000	65,000	-75,000	17,000	17,000	16,000	14,000	15,000
non-cash interest expense											1,150,000	-28,000	63,000	0	2,000	155,000	213,000	243,000	150,000	257,000	257,000
gain from the change in fair value of 2020/21 notes and 2020 notes embedded derivative liability
loss on conversion of 2020/21 notes to common stock																1,373,000
acquisition of patents
proceeds from sale of marketable securities												45,242,000
investment in juhl																				0
payment on loans payable - other
proceeds from sba loans																	0
net increase in cash and cash equivalents and restricted cash
cash, cash equivalents and restricted cash
beginning of year
end of year
gain from change in fair value of derivative warrant liability													-6,000	-43,000	53,000
gain from change in fair value of 2020/21 notes and 2020 notes embedded derivative liability
other non-cash expenses													0
accounts payable, accrued expenses and long-term liabilities													556,000
net increase (decrease) in cash and cash equivalents													-9,021,000
cash, cash equivalents and restricted cash
beginning of period													0	0	78,338,000		0	0	16,302,000		0
end of period													-9,021,000	-380,129,000	525,323,000		74,284,000	-2,952,000	9,289,000		-8,211,000
loss from change in fair value of 2020/21 notes embedded derivative liability
(gain) on forgiveness of sba ppp loans
proceeds from sba ppp loans
income from change in fair value of 2020/21 notes embedded derivative liability
cash and cash equivalents
gain from the change in fair value of derivative warrant liability
gain from the change in fair value of 2020/21 notes and 2020 notes embedded derivative
loss on sale of property, plant and equipment
payment on secured debt
proceeds from sba loan
(gain) from change in fair value of derivative warrant liability																	0	-1,000	-7,000
gain from change in fair value of 2020/21 notes and 2020 notes embedded derivative liability																	-247,000
gain on retirement of property, plant and equipment
other non-cash expense																					0
loss on retirement of property, plant and equipment
proceeds from issuance of common stock																		1,313,000	958,000		0
(gain) from change in fair value of 2020/21 notes and 2020 notes embedded derivative liability																			100,000
accounts payable, accrued expenses, and long-term liabilities																			-1,150,000
(gain) income from the change in fair value of derivative warrant liability
(gain) from the change in fair value of the embedded derivative to the 2020 notes
loss on exchange or conversion of debt
payments on secured debt
(gain) income from change in fair value of derivative warrant liability																					2,000
(gain) from change in fair value of 2020 notes embedded derivative																					0
(gain) on sale of property, plant and equipment
loss on exchange of debt
proceeds from exercise of common stock warrants
cash, cash equivalent and restricted cash
loss/(gain) from the change in fair value of derivative warrant liability
income from the change in fair value of 2017 notes
loss on extinguishment of warrant liability
loss on issuance of equity
prepaid expenses and other current assets
proceeds from sales tax refund for property, plant and equipment
cash, cash equivalents, and restricted cash
ending of year
(gain) from the change in fair value of derivative warrant liability
loss/(gain) on exchange or conversion of debt
loss/(gain) on extinguishment of warrant liability
proceeds from issuance of common stock upon exercise of stock options and employee stock purchase plan
release of restricted cash held as collateral on 2017 notes
(gain) from the change in fair value of the embedded derivative to the 2022 notes
loss/(gain) from the change in fair value of 2017 notes
restricted certificate of deposit
proceeds from issuance of convertible debt
gain from change in fair value of embedded derivative of the 2022 notes
gain from change in fair value of 2017 notes
(gain) loss on extinguishment of debt
gain on extinguishment of warrant liability
income from change in fair value of derivatives
other
deposit on secured debt and other
non-cash stock-based compensation
loss on conversion of debt
gain from change in fair value of derivatives
deposits and other assets
restricted deposits
proceeds from sales tax refund
proceeds from issuance of 2017 notes
proceeds from issuance of secured debt
net (decrease) in cash and cash equivalents
income from change in fair value of warrant liabilities
gain from change in fair value of embedded derivative
changes in operating assets and liabilities
acquisition of agri-energy, net of cash assumed
proceeds from issuance of common stock and common stock units
proceeds from issuance of common stock upon exercise of stock options and espp
proceeds from issuance of convertible preferred stock
proceeds from issuance of convertible promissory notes with warrants
(gain) income from change in fair value of derivatives
cash flows from operating activities:
stock expense for shares issued pursuant to license agreements
non-cash interest expense and amortization of debt discounts and debt issue costs to non-cash interest expense
gain from change in derivative
loss on abandonment or disposal of fixed assets
margin deposit
cash flows from investing activities:
acquisition of agri-energy, net of cash acquired
proceeds from the sale of property and equipment
cash flows from financing activities:
proceeds from issuance of common stock pursuant to employee stock purchase plan
proceeds from issuance of convertible promissory notes with warrant
proceeds from issuance of secured long-term debt
proceeds from issuance of warrants
payments on secured long-term debt
deposit on secured long-term debt
proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions
deferred offering costs
debt issue costs
payment of stock issuance costs
cash and cash equivalents:
ending of period
supplemental disclosures of non-cash transactions—investing and financing:
conversion of preferred stock warrants to common stock warrants upon initial public offering and reclassification of related liability to additional paid-in capital
warrants issued with secured long-term debt
warrants issued with convertible promissory notes
noncash interest expense and amortization of debt discounts and debt issue costs to noncash interest expense
payment of principal and final payment on secured long-term debt
supplemental disclosures of noncash transactions—investing and financing:
promissory notes and accrued interest converted to series c preferred stock
issuance of common stock pursuant to license agreements
issuance of series c preferred stock upon exercise of warrant
issuance of series d-1 preferred stock to icm, inc. in exchange for a credit against future services

We provide you with 20 years of cash flow statements for Gevo stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Gevo stock. Explore the full financial landscape of Gevo stock with our expertly curated income statements.

The information provided in this report about Gevo stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.